AirSculpt Technologies (AIRS) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue declined 9.1% year-over-year to $42.5 million, with case volume down 4.3% and same-store cases down 8.1%.

• Net loss widened to $6.0 million for Q3 2024 from $1.7 million in Q3 2023; Adjusted EBITDA was $4.7 million (11% margin), down from $9.1 million (19.4% margin) in Q3 2023.

• Four new centers opened in Q3, bringing the total to 31 facilities as of September 30, 2024, across 20 states, Canada, and the UK.

• Cost savings initiatives achieved $500,000 in Q3, with $2 million annualized savings expected.

• Focus remains on lead conversion, new center ramp-up, and cost management initiatives.

Financial highlights

• Q3 2024 revenue was $42.5 million, down 9.1% year-over-year; same-store revenue declined 13%.

• Q3 case volume was 3,277, down 4.3% year-over-year; average revenue per case was $12,984, down from $13,658.

• Cost of service as a percentage of revenue increased to 41.8% from 38.8% year-over-year, impacted by new center openings and fixed costs.

• SG&A expenses rose to 59.9% of revenue in Q3 2024, up from 53.5% in Q3 2023; corporate G&A was reduced by $500,000 sequentially.

• Cash at quarter-end was $6 million, with $5 million available on the revolver; gross debt was $71.3 million, leverage ratio 2.2x.

Outlook and guidance

• 2024 revenue guidance midpoint raised to $183–$189 million; full-year Adjusted EBITDA guidance maintained at $23–$28 million.

• Management expects continued investment in marketing and corporate support as new centers open, with a focus on long-term growth despite near-term margin pressure.

• Liquidity is expected to be sufficient for working capital, capital expenditures, and debt payments for at least the next 12 months.

• Pipeline includes three new centers identified for 2025, with plans to expand further.

• Expect further improvement in cost of service and CAC as new centers ramp and marketing spend is optimized.